Followers | 74 |
Posts | 36574 |
Boards Moderated | 0 |
Alias Born | 02/11/2017 |
Thursday, April 04, 2024 5:23:06 AM
Recent KTRA News
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 08/08/2024 09:30:36 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 07/19/2024 09:03:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:17:26 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/08/2024 10:45:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 10:40:09 AM
- TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor • PR Newswire (US) • 07/08/2024 10:30:00 AM
- Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones • PR Newswire (US) • 07/01/2024 12:35:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/13/2024 08:10:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:11 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/03/2024 12:50:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:45:11 PM
- TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) • PR Newswire (US) • 06/03/2024 12:35:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/17/2024 08:10:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/17/2024 08:05:37 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/14/2024 08:55:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:50:14 PM
- Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results • PR Newswire (US) • 05/14/2024 08:45:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:40:36 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 05/13/2024 08:06:50 PM
- Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
- Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement • PR Newswire (US) • 04/03/2024 11:00:00 AM
- Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab • PR Newswire (US) • 03/27/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:59:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:00:10 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM